TipRanks
MiraeING Co., Ltd. (KR:007120)
:007120
South Korea Market
Want to see KR:007120 full AI Analyst Report?

MiraeING Co., Ltd. (007120) AI Stock Analysis

― Followers

Top Page

KR:007120

MiraeING Co., Ltd.

(007120)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - Gpt-5.6Sol)
Rating:54Neutral
Price Target:
₩1,042.00
Action:N/A
Date:10/28/26
The score is primarily supported by strong, consistent cash generation and manageable leverage, but is held back by persistent net losses/negative shareholder returns and a weaker technical trend (below key moving averages with negative MACD). Valuation is also constrained by the loss-making profile (negative P/E) and lack of dividend data.
Positive Factors
Strong cash generation
Consistently positive operating and free cash flow provides internal funding capacity and supports financial resilience. This cash generation can help the company maintain operations, pursue investments, and manage obligations even while reported earnings remain weak.
Negative Factors
Persistent net losses
Persistent net losses and negative returns on equity show that operating strength has not translated into durable shareholder profitability. This limits retained earnings, weakens the quality of reported performance, and makes sustained bottom-line improvement an important execution requirement.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Consistently positive operating and free cash flow provides internal funding capacity and supports financial resilience. This cash generation can help the company maintain operations, pursue investments, and manage obligations even while reported earnings remain weak.
Read all positive factors

MiraeING Co., Ltd. (007120) vs. SPDR S&P 500 ETF (SPY)

MiraeING Co., Ltd. Business Overview & Revenue Model

Company Description
MiraeING Co., Ltd. engages in the provision of financial solutions. It operates through the Solution and B&E business divisions. The Solution division focuses on solution development and maintenance. The B&E division deals with BioCosmetics, Enter...

MiraeING Co., Ltd. Financial Statement Overview

Summary
Financials are mixed: strong and consistent operating/free cash flow (~7.3B TTM) and moderate leverage (debt-to-equity ~0.33) support stability, but the company still reports net losses (net margin ~-21%) and negative ROE, with revenue down in TTM (~-7%).
Income Statement
48
Neutral
Balance Sheet
70
Positive
Cash Flow
76
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.41B14.13B11.70B13.03B12.83B7.81B
Gross Profit7.25B7.05B5.50B6.61B6.59B3.51B
EBITDA7.01B6.50B-2.03B-4.22B-2.56B-10.19B
Net Income-3.00B-1.62B-8.04B-9.30B-3.04B-18.08B
Balance Sheet
Total Assets68.19B72.76B74.87B89.54B97.49B99.67B
Cash, Cash Equivalents and Short-Term Investments25.38B17.61B13.17B8.81B23.83B35.28B
Total Debt15.48B16.71B18.97B21.03B22.98B24.44B
Total Liabilities20.60B24.11B23.90B31.39B28.06B28.59B
Stockholders Equity47.59B48.64B50.97B58.14B69.39B71.08B
Cash Flow
Free Cash Flow7.31B7.14B5.05B7.09B4.31B1.47B
Operating Cash Flow7.36B7.26B5.10B7.16B5.71B2.02B
Investing Cash Flow8.47B-86.74M-5.22B-18.69B-15.14B-22.11B
Financing Cash Flow-3.93B-3.48B-2.57B-3.48B-1.97B1.18B

MiraeING Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
1071.66
Negative
100DMA
1141.29
Negative
200DMA
1338.14
Negative
Market Momentum
MACD
-9.86
Negative
RSI
44.21
Neutral
STOCH
35.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:007120, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 1006.00, equal to the 50-day MA of 1071.66, and equal to the 200-day MA of 1338.14, indicating a bearish trend. The MACD of -9.86 indicates Negative momentum. The RSI at 44.21 is Neutral, neither overbought nor oversold. The STOCH value of 35.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:007120.

MiraeING Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
₩25.30B-8.92――22.76%72.20%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KR:007120
MiraeING Co., Ltd.
982.00
160.00
19.46%
KR:131220
Daihan Scientific Co., Ltd
3,630.00
-1,006.19
-21.70%
KR:215790
INNO INSTRUMENT INC.
2,390.00
-225.00
-8.60%
KR:335810
Precision Biosensor, Inc.
1,435.00
-1,085.00
-43.06%
KR:351320
Nexa Dynamics Co. Ltd.
5,200.00
3,603.00
225.61%
KR:351330
ISAAC Engineering Co. Ltd.
2,750.00
-6,060.00
-68.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 28, 2026